Biotechnology financing dilemmas and the role of special purpose entities Export

@article{citeulike:5014341, abstract = {Before they fell into disfavor, legally independent affiliates of biotech companies - special purpose entities - had supported the development of several blockbuster drugs. Are they about to stage a comeback?}, author = {Schiff, Leora and Murray, Fiona}, citeulike-article-id = {5014341}, journal = {Nature Biotechnology}, keywords = {biotech, collaborative, enron, innovation, investors, ipr, spe}, month = {March}, number = {3}, posted-at = {2009-06-29 17:46:09}, priority = {2}, title = {Biotechnology financing dilemmas and the role of special purpose entities}, volume = {22}, year = {2004} }

TY - JOUR ID - citeulike:5014341 L3 - citeulike-article-id:5014341 N2 - Before they fell into disfavor, legally independent affiliates of biotech companies - special purpose entities - had supported the development of several blockbuster drugs. Are they about to stage a comeback? IS - 3 JF - Nature Biotechnology TI - Biotechnology financing dilemmas and the role of special purpose entities VL - 22 KW - biotech KW - collaborative KW - enron KW - innovation KW - investors KW - ipr KW - spe AU - Schiff, Leora AU - Murray, Fiona PY - 2004/03// ER -